Literature DB >> 2478256

Evidence for an excitatory amino acid pathway in the brainstem and for its involvement in cardiovascular control.

P Somogyi1, J B Minson, D Morilak, I Llewellyn-Smith, J R McIlhinney, J Chalmers.   

Abstract

The source and possible role of excitatory amino acid projections to areas of the ventrolateral medulla (VLM) involved in cardiovascular control were studied. Following the injection of [3H]D-aspartate ([3H]D-Asp), a selective tracer for excitatory amino acid pathways, into vasopressor or vasodepressor areas of the VLM in rats, more than 90% of retrogradely labelled neurones were found in the nucleus of the solitary tract (NTS). Very few of the [3H]D-Asp-labelled cells were immunoreactive for tyrosine hydroxylase, none for phenylethanolamine-N-methyltransferase or gamma-aminobutyric acid. The density of labelled cells in the NTS was similar to that obtained with the non-selective tracers wheat germ agglutinin-horseradish peroxidase (WGA-HRP) and WGA-colloidal gold, but these tracers also labelled other cell groups in the medulla. Furthermore, the decrease in blood pressure, caused by pharmacological activation of neurones in the NTS of rats, or by electrical stimulation of the aortic depressor nerve in rabbits could be blocked by the selective N-methyl-D-aspartate (NMDA) receptor antagonist 2-amino-5-phosphonovalerate injected into the caudal vasodepressor area of the VLM. This area corresponds to the termination of [3H]D-Asp transporting NTS neurones. These results provide evidence that a population of NTS neurones projecting to the VLM use excitatory amino acids as transmitters. Among other possible functions, this pathway may mediate tonic and reflex control of blood pressure via NMDA receptors in the VLM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478256     DOI: 10.1016/0006-8993(89)91097-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Functional organization of brain pathways subserving the baroreceptor reflex: studies in conscious animals using immediate early gene expression.

Authors:  Roger A L Dampney; Jaimie W Polson; Patrick D Potts; Yoshitaka Hirooka; Jouji Horiuchi
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

2.  On the role of NMDA receptors in blood pressure regulation in spontaneously hypertensive rats (SHR).

Authors:  S Glazewski; M Remiszewska; M Wutkiewicz; Z Jastrzebski; W Danysz
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

3.  Excitatory amino acid-mediated chemoreflex excitation of respiratory neurones in rostral ventrolateral medulla in rats.

Authors:  M K Sun; D J Reis
Journal:  J Physiol       Date:  1996-04-15       Impact factor: 5.182

4.  Ipsilateral but not contralateral blockade of excitatory amino acid receptors in the caudal ventrolateral medulla inhibits aortic baroreceptor reflex in rats.

Authors:  T Kubo; M Kihara; Y Misu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

5.  Excitatory amino acid receptors in the rostral ventrolateral medulla mediate hypertension induced by carotid body chemoreceptor stimulation.

Authors:  M Amano; T Asari; T Kubo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

6.  Blockade of excitatory amino acid receptors in the ventrolateral medulla does not abolish the cardiovascular actions of L-glutamate.

Authors:  Z J Gieroba; W W Blessing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

7.  Interaction of medullary P2 and glutamate receptors mediates the vasodilation in the hindlimb of rat.

Authors:  Willian Seiji Korim; Marcos L Ferreira-Neto; Gustavo R Pedrino; Paul M Pilowsky; Sergio L Cravo
Journal:  Purinergic Signal       Date:  2012-05-11       Impact factor: 3.765

Review 8.  Different types of centrally acting antihypertensives and their targets in the central nervous system.

Authors:  P A van Zwieten; J P Chalmers
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.